David Stocker

David Stocker has a diverse work experience. In 2021, they began working as a Technical Scientist for CDR-Life Inc. In 2020, they completed a Master Thesis at ETH Zürich, where they synthesized and evaluated novel ATP5A ligands for PET tracer development. In 2019, they worked on a research project at ETH Zürich, where they did kinetic modeling of intravenous administered Busulfan in children and young adults. David also worked as a Teaching Assistant for the Practical Course Galenics and Pharmaceutical Analytics at ETH Zürich in 2019 and 2018 respectively. Prior to this, they worked as a Student Job in Sale at Manor AG in 2017 and in Office/Administration at Confiseur Bachmann AG in 2014.

David Stocker obtained their Matura from Kantonsschule Alpenquai Luzern in 2014, with a focus on biology and chemistry. David then attended ETH Zürich from 2015 to 2019, graduating with a Bachelor of Science in Pharmaceutical Sciences. David subsequently returned to ETH Zürich, where they earned a Master of Science in Pharmaceutical Sciences in 2021. In 2020, they also obtained a Yellow Belt Process Improvement certification from Stanwick Management Consultants.